Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"FENOLDOPAM"”.
-
Effect of Fenoldopam on Renal Function in Normal Dogs Following Nephrotomy
Objective: To evaluate the effect of fenoldopam on renal function in normal dogs subjected to bisection nephrotomy. In addition, effects of bisection nephrotomy on renal function in normal dogs were evaluated. Study Design: Controlled, randomized, blinded experiment Sample Population: Sixteen mixed …
-
Η ΑΙΜΟΔΥΝΑΜΙΚΗ ΦΑΡΜΑΚΙΝΗΤΙΚΗ ΜΕΛΕΤΗ ΤΗΣ FENOLDOPAM ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΚΙΡΡΩΣΗ ΤΟΥ ΥΠΑΤΟΣ
… EFFECTS, AS WELL AS THE PHARMACOKYNETICS OF FENOLDOPAM, A SELECTIVE AGONIST OF THE POSTSYNAPTIC DOPAMINERGIC RECEPTORS WERE STUDIED, IN PATIENTS WITH LIVER CIRRHOSIS. A PILOT STUDY OF INTRAVENOUSLY ADMINISTERED FENOLDOPAM WAS INITIALLY CARRIED OUT IN 5 PATIENTS, IN INCREASING DOSES OD 0,05 TO …
-
Intervenções farmacológicas para prevenção de nefropatia induzida por contraste : uma aplicação do método do tamanho ótimo da informação corrigido para heterogeneidade a fim de determinar se as evidências de uma metanálise são definitivas e conclusivas
… teofilina, 4 estudos com dopamina, 3 estudos com fenoldopam e 2 estudos com furosemida) e realizamos 5 metanálises separadas (uma para cada intervenção). A maioria dos estudos era de baixa qualidade metodológica (40,4% eram duplo-cego, 25% tinham sigilo da lista de alocação e 15,4% reportaram …
-
Characterizing the Role of Paraoxonase 2 (PON2) in the Brain: Phenotypic Analysis and Modulating Factors
… increase the expression of PON2 in-vitro, while fenoldopam, a dopamine receptor 1/5 (DRD1/5) agonist did not, suggesting PON2 plays a role in DRD2-specific signaling. Finally, I collected preliminary data suggesting PON2 deficiency impacts numerous targets relevant to neurodegenerative disease, …
-
Synthetic and Biological Studies on Benzazepine Derivatives as Dopamine Receptor Ligands
… as research tools in pharmacological studies. Fenoldopam (2, Figure 4), a selective D1R-like partial agonist, is currently the only compound from this class in use clinically (as a fast-acting anti-hypertensive drug). In addition to being potential therapeutic agents for Parkinson’s and …